Table 3.
Association between clinical characterstics and MPN-SAF Total Symptom Score in MF patients
| Total Symptom Score (TSS) (mean, SD) | p-value | |
|---|---|---|
| n = 418 | ||
| Anemia (Hgb < 11 g/dL) | < 0.001 | |
| Yes | 29.6 (18.4) | |
| No | 22.3 (15.6) | |
| Leukopenia (WBC < 3.5 × 109/L) | 0.06 | |
| Yes | 29.9 (19.3) | |
| No | 25.3 (17.1) | |
| Lab abnormality | < 0.001 | |
| Yes | 28.7 (18.1) | |
| No | 21.5 (15.6) | |
| Required RBC transfusion | 0.003 | |
| Yes | 30.8 (19.0) | |
| No | 24.6 (16.8) | |
| DIPSS risk | < 0.001 | |
| Low | 15.2 (11.1) | |
| Intermediate-1 | 23.3 (15.4) | |
| Intermediate-2/High | 31.5 (17.1) |
DIPSS, Dynamic International Prognostic Scoring System; Hgb, hemoglobin; MF, myelofibrosis; RBC, red blood cell; SD, standard deviation; WBC, white blood cell.